Alessa Therapeutics
Phase 1Alessa Therapeutics is developing a proprietary drug-delivery platform for sustained and localized release of clinically proven therapies to effectively treat early-stage prostate cancer
Founded
2020
Focus
Drug Delivery
About
Alessa Therapeutics is developing a proprietary drug-delivery platform for sustained and localized release of clinically proven therapies to effectively treat early-stage prostate cancer
Funding History
1Total raised: $4.5M
Seed$4.5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2020
LocationSan Diego, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile